Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders

OBJECTIVE: To evaluate if short‐term treatment with everolimus was safe and could improve neurocognition and behavior in children with TSC. METHODS: This was a prospective, double‐blind randomized, placebo‐controlled two‐center phase II study. Participants diagnosed with TSC and age 6–21 years were...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Clin Transl Neurol
Glavni autori: Krueger, Darcy A., Sadhwani, Anjali, Byars, Anna W., de Vries, Petrus J., Franz, David N., Whittemore, Vicky H., Filip‐Dhima, Rajna, Murray, Donna, Kapur, Kush, Sahin, Mustafa
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Research Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740257/
https://ncbi.nlm.nih.gov/pubmed/29296616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.494
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items